Bias Characterization of Real-World Patients With and Without Imaging in a Community Oncology Electronic Health Records Database

Author(s)

Li X1, Ackerman B1, Magee K2, Kern J1, Tan WK1
1Flatiron Health, New York, NY, USA, 2Flatiron Health, New York , NY, USA

OBJECTIVES: Radiology imaging is critical to diagnose and monitor cancer. However, real-world radiographic imaging data availability and timing for patients may vary, and selecting real-world patients based on imaging availability may introduce biases, potentially impacting generalizability of results. Therefore, we assessed the representativeness of imaging-derived cohorts relative to a broader real-world oncology target population.

METHODS: We used the nationwide Flatiron Health electronic health record (EHR)-derived de-identified Research Database (FHRD) linked to retrospective radiographic imaging data to select two broad study cohorts, patients with advanced non-small cell lung cancer (aNSCLC) and patients with diffuse large B-cell lymphoma (DLBCL), both with the receipt of first-line (1L) treatment as of November 30, 2021. For each respective cohort, our comparisons were based on imaging availability at various time points: any time point, baseline (pre-1L initiation), baseline and post-baseline (during 1L duration). Differences in baseline demographic, clinical, and treatment characteristics between groups were measured through the absolute standardized mean difference (ASMD), with a threshold of 0.1.

RESULTS: There were 12,170 and 1,508 patients in the FHRD imaging-linked aNSCLC and DLBCL cohorts. For both diseases, patients with scans at any time point or in baseline window were broadly representative to the respective target. However, requiring scans at both baseline and post-baseline windows resulted in some covariate and outcome differences with the target cohort. For the aNSCLC cohort, longer median rwOS (+4 months) was observed. For the DLBCL cohort, we saw an increase in lower ECOG performance scores (+20%).

CONCLUSIONS: Requiring scans at any time point or in the baseline window resulted in the cohort being representative relative to the broader real-world cohort; however, requiring scans in the post-baseline window may introduce selection and immortal time bias. Further work is needed to assess the application of existing methods to account for such biases in this context.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

RWD49

Topic

Medical Technologies, Methodological & Statistical Research, Study Approaches

Topic Subcategory

Confounding, Selection Bias Correction, Causal Inference, Diagnostics & Imaging, Electronic Medical & Health Records

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×